PERI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 32.427
EU - Europa 16.142
AS - Asia 7.579
SA - Sud America 1.171
AF - Africa 132
Continente sconosciuto - Info sul continente non disponibili 19
OC - Oceania 17
Totale 57.487
Nazione #
US - Stati Uniti d'America 31.966
DE - Germania 5.575
DK - Danimarca 2.806
IT - Italia 2.440
CN - Cina 2.209
SG - Singapore 2.110
RU - Federazione Russa 1.183
HK - Hong Kong 1.131
VN - Vietnam 1.120
BR - Brasile 986
SE - Svezia 869
IE - Irlanda 627
UA - Ucraina 517
GB - Regno Unito 469
PL - Polonia 391
CA - Canada 363
FR - Francia 350
AT - Austria 229
IN - India 211
FI - Finlandia 198
NL - Olanda 159
KR - Corea 156
ID - Indonesia 130
TR - Turchia 95
BE - Belgio 94
JP - Giappone 90
BD - Bangladesh 79
ES - Italia 75
MX - Messico 64
AR - Argentina 61
ZA - Sudafrica 57
IQ - Iraq 44
EC - Ecuador 37
RO - Romania 30
PK - Pakistan 28
IR - Iran 27
CH - Svizzera 25
LT - Lituania 25
UZ - Uzbekistan 20
CO - Colombia 18
MA - Marocco 18
CL - Cile 17
IL - Israele 16
PY - Paraguay 16
TW - Taiwan 16
VE - Venezuela 15
CZ - Repubblica Ceca 14
AE - Emirati Arabi Uniti 13
AU - Australia 12
EG - Egitto 12
EU - Europa 12
GR - Grecia 12
SA - Arabia Saudita 12
KE - Kenya 11
AZ - Azerbaigian 10
MY - Malesia 10
PT - Portogallo 10
NP - Nepal 9
PH - Filippine 9
DZ - Algeria 8
PE - Perù 8
TN - Tunisia 8
BG - Bulgaria 7
ET - Etiopia 7
UY - Uruguay 7
JM - Giamaica 6
NO - Norvegia 6
TT - Trinidad e Tobago 6
AL - Albania 5
BB - Barbados 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
JO - Giordania 5
MU - Mauritius 5
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
KZ - Kazakistan 4
RS - Serbia 4
SC - Seychelles 4
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
GY - Guiana 3
LV - Lettonia 3
PA - Panama 3
SY - Repubblica araba siriana 3
A1 - Anonimo 2
BA - Bosnia-Erzegovina 2
EE - Estonia 2
MN - Mongolia 2
NG - Nigeria 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
BN - Brunei Darussalam 1
CU - Cuba 1
DM - Dominica 1
GE - Georgia 1
Totale 57.470
Città #
Ann Arbor 19.992
Frankfurt am Main 5.145
Singapore 1.221
Ashburn 1.189
Woodbridge 1.151
Hong Kong 1.119
Wilmington 1.092
Chandler 942
Fairfield 884
Milan 775
Houston 609
Dublin 601
Jacksonville 504
Seattle 368
Beijing 336
Kraków 329
Santa Clara 313
Dearborn 310
Ho Chi Minh City 291
Cambridge 268
Hefei 268
Rome 260
Princeton 232
New York 223
Dong Ket 220
Vienna 207
Los Angeles 193
Nanjing 185
Hanoi 184
Dallas 151
Shanghai 150
Seoul 147
Boardman 145
Altamura 131
Guangzhou 130
Chicago 117
Jakarta 115
Toronto 112
São Paulo 110
Lawrence 107
Council Bluffs 88
Brussels 84
Lachine 80
San Diego 80
Buffalo 79
Moscow 77
Helsinki 63
Tokyo 62
Munich 58
Florence 57
Ottawa 49
Fremont 44
Jinan 44
Warsaw 44
Tianjin 43
Falls Church 42
London 42
Amsterdam 41
Hangzhou 40
Montréal 39
Hebei 38
Shenyang 38
Brooklyn 37
Nanchang 37
Phoenix 37
Andover 36
Nuremberg 35
Changsha 34
Hyderabad 34
Turin 34
Montreal 32
Huizen 29
Johannesburg 29
Kent 29
Brasília 28
Chennai 28
Norwalk 28
Rio de Janeiro 28
Denver 27
Salt Lake City 26
Zhengzhou 26
Atlanta 25
Brescia 25
Columbus 25
Jiaxing 25
Mountain View 25
Orem 25
Stockholm 24
Paris 23
Turku 23
Ha Long 22
Monza 22
Biên Hòa 21
Bologna 21
Desio 21
Boston 20
Can Tho 20
Kunming 20
Tashkent 20
The Dalles 20
Totale 43.079
Nome #
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties 759
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 735
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 722
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model 706
Structural characterization of aerogels derived from enzymatically oxidized galactomannans of fenugreek, sesbania and guar gums 699
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 661
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives 648
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)-and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling 629
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand 624
Dye-sensitized photocatalytic hydrogen production: Distinct activity in a glucose derivative of a phenothiazine dye 614
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection 614
Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid 593
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 591
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 588
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 578
Functional characterization of E. coli LptC: Interaction with LPS and a synthetic ligand 577
Dye-Sensitized Photocatalytic Hydrogen Generation: Efficiency Enhancement by Organic Photosensitizer-Coadsorbent Intermolecular Interaction 574
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling 571
Binding properties and biological characterization of new sugar-derived Ras ligands 569
A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line 566
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic 564
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108 557
Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity 553
Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization 552
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 551
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies 549
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice 547
Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update 544
Trehalose- and glucose-derived glycoamphiphiles: Small-molecule and nanoparticle toll-like receptor 4 (TLR4) modulators 544
A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity 541
Exploring the LPS/TLR4 signal pathway with small molecules 540
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties 537
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling 536
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists 526
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 522
Synthesis and biological evaluation of novel lipid A antagonists 521
Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: a new generation of immunotherapeutics 519
How do viruses interfere with Toll-like receptor 4? 515
The cationic amphiphile 3,4-bis (tetradecyloxy) benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding 510
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets 505
A new isoluminol reagent for chemiluminescence labeling of proteins 504
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling 493
Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides 492
Modulation of LPS signaling through TLR4 agonists and antagonists 489
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 484
Design and characterisation of a new class of inhibitors of Ras activation 483
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis 482
Sugar-derived Ras inhibitors: group epitope mapping by NMR spectroscopy and biological evaluation 481
Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof 480
Clustered carbohydrates in synthetic vaccines 479
Multivalent glycoconjugates as anti-pathogenic agents 477
Evidence of a specific interaction between new synthetic antisepsis agents and CD14 475
Rigid polycycles and peptidomimetics from carbohydrate synthons 470
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 467
Editorial 467
Optimizing operating conditions and electrochemical characterization of glucose-gluconate alkaline fuel cells 461
Glycoconjugates in cancer therapy 460
Carbohydrate-based bioactive compounds for medicinal chemistry applications 460
Arabinose-derived Bicyclic Amino Acids: Synthesis, Conformational Analysis and Construction of an avb3-selective RGD Peptide 455
Chemoselective neoglycosylation 452
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR 447
Chemistry of lipid a: At the heart of innate immunity 446
Looking forward: A glance into the future of organic chemistry 445
Studies on the mechanism of action of a new class of inhibitors of Ras activation 438
Carbohydrate Scaffolds for the Production of Bioactive Compounds 436
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development 434
Sugar-derived amino acids: powerful secondary structure inducing elements in the design of novel peptidomimetics 432
Novel α-conotoxin from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcoline receptors 431
Polycyclic Scaffolds from Fructose 429
Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues 428
Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: New multivalent galectin-3 ligands 425
Glycoconjugate and oligosaccharide mimetics by chemoselective ligation 423
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope 423
Assembly of binding loops on aromatic templates as V CAM-1 mimetics 423
Sugar-Based Inhibitors of Ras Activation: Biological Activity and Identification of Ras–Inhibitor Binding Interface 423
Chemoselective Ligation in Glycochemistry 422
Extending chemoselective ligation to sugar chemistry:convergent assembly of bioactive neoglycoconjugates 419
Discrimination Properties of Tetraamidic Branched Selectors 418
Synthesis of imino-C-disaccharides related to sucrose 416
The EuroSciCon's 2015 Innate Immunity Summit 415
The Role of TLR4 in Neural Stem Cells–Mediated Neurogenesis and Neuroinflammation 414
Synthesis of imino sugar scaffolds for the generation of glycosidase inhibitor libraries 413
Carbohydrate-based Scaffolds for the generation of sortiments of bioactive compounds 411
A new procedure for the synthesis of C-glycosides of nojirimycin 411
Synthesis of bicyclic sugar azido acids and their incorporation in cyclic peptides 405
Stepwise synthesis and structural characterization of calix[4]- and calix[5]arenes bearing a functionalized arm on the methylene bridge 404
Chemoselective glycosylation techniques for the synthesis of bioactive neoglycoconjugates, glyconanoparticles and glycoarrays 404
Stereoselective synthesis of α-C-glycosides of N-acetylgalactosamine 401
Conversion of lactose into mimics of N-acetyllactosamine 401
D-glucose as a regioselectively addressable scaffold for combinatorial chemistry on solid phase 401
Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles 399
Lipid A antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity 395
The bone morphogenic protein antagonist Drm/gremlin is a novel pro- angiogenic factor 395
Regioselection and orthogonality of the 1-phenyl-3-butenyl (PBU) protecting group in glucopyranosides 393
Bicyclic carbohydrate-derived scaffolds for combinatorial libraries 391
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants 389
Glycidic scaffolds in Peptidomimetic synthesis 384
Chemo- and stereoselective glycosylation of hydroxylamino derivatives: A versatile approach to glycoconjugates 383
Synthesis and conformational analysis of novel N(OCH3) disaccharide analogues 380
Novel Tn antigen containing neoglycopeptides: synthesis and evaluation as antitumour vaccines 374
Totale 49.383
Categoria #
all - tutte 137.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.573


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218.168 0 0 0 0 942 978 1.033 1.187 911 1.052 816 1.249
2021/202211.080 1.142 1.083 967 1.112 887 869 785 847 676 868 787 1.057
2022/20238.296 1.376 1.724 1.100 997 928 1.111 161 295 250 175 104 75
2023/20242.842 84 188 345 160 351 433 448 141 184 86 110 312
2024/20256.194 324 548 455 326 461 300 334 353 588 926 547 1.032
2025/20266.676 1.885 981 1.133 1.638 1.039 0 0 0 0 0 0 0
Totale 58.856